
October to December 2021
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| AFLIBERCEPT | $123,404,892 | 103,510 |
| PEMBROLIZUMAB | $112,338,813 | 13,214 |
| NIVOLUMAB | $103,449,139 | 13,377 |
| USTEKINUMAB | $76,381,293 | 10,714 |
| APIXABAN | $75,433,437 | 893,397 |
| ADALIMUMAB | $70,405,870 | 78,330 |
| DENOSUMAB | $68,250,850 | 269,889 |
| LENALIDOMIDE | $62,480,057 | 11,362 |
| RANIBIZUMAB | $50,500,156 | 43,631 |
| OCRELIZUMAB | $48,195,484 | 2,776 |
| RIVAROXABAN | $45,213,099 | 650,588 |
| IPILIMUMAB | $39,654,177 | 1,985 |
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| ROSUVASTATIN | $30,460,072 | 3,995,227 |
| ATORVASTATIN | $26,212,819 | 3,139,594 |
| PANTOPRAZOLE | $21,315,274 | 2,572,305 |
| ESOMEPRAZOLE | $25,869,926 | 2,221,574 |
| PERINDOPRIL | $13,531,887 | 1,831,285 |
| METFORMIN | $14,179,530 | 1,546,688 |
| ESCITALOPRAM | $7,113,224 | 1,512,301 |
| SERTRALINE | $7,133,450 | 1,414,143 |
| AMLODIPINE | $8,881,607 | 1,229,661 |
| CEFALEXIN | $6,259,813 | 1,143,618 |
| TELMISARTAN | $8,097,305 | 1,143,395 |
| PREGABALIN | $17,385,637 | 1,089,204 |
| Contributor | Contribution Dollars |
|---|---|
| Australian Government | $3,908,839,878 |
| Patients | $747,844,600 |